These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7741767)

  • 1. Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program.
    Cleaveland ES; Monks A; Vaigro-Wolff A; Zaharevitz DW; Paull K; Ardalan K; Cooney DA; Ford H
    Biochem Pharmacol; 1995 Mar; 49(7):947-54. PubMed ID: 7741767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redoxal as a new lead structure for dihydroorotate dehydrogenase inhibitors: a kinetic study of the inhibition mechanism.
    Knecht W; Löffler M
    FEBS Lett; 2000 Feb; 467(1):27-30. PubMed ID: 10664450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
    Cleaveland ES; Zaharevitz DW; Kelley JA; Paull K; Cooney DA; Ford H
    Biochem Biophys Res Commun; 1996 Jun; 223(3):654-9. PubMed ID: 8687451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of inhibition of human and rat dihydroorotate dehydrogenase by atovaquone, lawsone derivatives, brequinar sodium and polyporic acid.
    Knecht W; Henseling J; Löffler M
    Chem Biol Interact; 2000 Jan; 124(1):61-76. PubMed ID: 10658902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
    Rückemann K; Fairbanks LD; Carrey EA; Hawrylowicz CM; Richards DF; Kirschbaum B; Simmonds HA
    J Biol Chem; 1998 Aug; 273(34):21682-91. PubMed ID: 9705303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.
    Chen SF; Perrella FW; Behrens DL; Papp LM
    Cancer Res; 1992 Jul; 52(13):3521-7. PubMed ID: 1617622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
    Seymour KK; Lyons SD; Phillips L; Rieckmann KH; Christopherson RI
    Biochemistry; 1994 May; 33(17):5268-74. PubMed ID: 7909690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).
    Peters GJ; Sharma SL; Laurensse E; Pinedo HM
    Invest New Drugs; 1987; 5(3):235-44. PubMed ID: 2822596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acivicin and dichloroallyl lawsone upon pyrimidine biosynthesis in mouse L1210 leukemia cells.
    Kemp AJ; Lyons SD; Christopherson RI
    J Biol Chem; 1986 Nov; 261(32):14891-5. PubMed ID: 3771555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malarial dihydroorotate dehydrogenase. Substrate and inhibitor specificity.
    Baldwin J; Farajallah AM; Malmquist NA; Rathod PK; Phillips MA
    J Biol Chem; 2002 Nov; 277(44):41827-34. PubMed ID: 12189151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects.
    Schwartsmann G; Peters GJ; Laurensse E; de Waal FC; Loonen AH; Leyva A; Pinedo HM
    Biochem Pharmacol; 1988 Sep; 37(17):3257-66. PubMed ID: 2840910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
    Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
    Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
    He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
    Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of brequinar and ciprofloxacin on de novo nucleotide biosynthesis in mouse L1210 leukemia.
    Lyons SD; Christopherson RI
    Biochem Int; 1990 Dec; 22(6):939-49. PubMed ID: 1965281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.
    Knecht W; Löffler M
    Biochem Pharmacol; 1998 Nov; 56(9):1259-64. PubMed ID: 9802339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase.
    Chen SF; Papp LM; Ardecky RJ; Rao GV; Hesson DP; Forbes M; Dexter DL
    Biochem Pharmacol; 1990 Aug; 40(4):709-14. PubMed ID: 2386542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine.
    Setzer B; Lebrecht D; Walker UA
    Am J Pathol; 2008 Mar; 172(3):681-90. PubMed ID: 18276780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "anti-pyrimidine effect" of hypoxia and brequinar sodium (NSC 368390) is of consequence for tumor cell growth.
    Löffler M
    Biochem Pharmacol; 1992 May; 43(10):2281-7. PubMed ID: 1599514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF; Ruben RL; Dexter DL
    Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.